IDXX
IDEXX Laboratories, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$532.70
+0.64%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
34.2x
EV/EBITDA
26.5x
Market Cap
$41.97B
MomentumView details →
1D Return
+0.64%
YTD Return
−21.75%
RSI (14)
38.1
ValuationView details →
P/E (Fwd)
34.2x
EV/EBITDA
26.5x
Market Cap
$41.97B
RSI (14)
38.1
MomentumView details →
1D Return
+0.64%
YTD Return
−21.75%
SummaryUpdated Jun 1, 2026
IDEXX Laboratories, Inc. (NASDAQ:IDXX) is a leading global provider of veterinary diagnostics and water quality testing solutions founded in 1983 and headquartered in Westbrook, Maine. The company went public in 1991 and has grown to become the dominant player in companion animal veterinary diagnostics, serving veterinary clinics, reference laboratories, and water testing markets worldwide. IDEXX operates through four main segments: Companion Animal Group (CAG), Water Quality Products, Livestock, Poultry and Dairy (LPD), and Other segments, with the companion animal business representing the vast majority of revenues and profits.
Similar companies
Latest newsMore news →
IDEXX Laboratories outlined at its 2026 Investor Day a pipeline of diagnostic, software, and AI offerings, including cancer tests, targeting a $45 billion global companion-animal testing opportunity.21d agoIDEXX launched the Catalyst proBNP Test, the first and only dual-species point-of-care NT-proBNP assay for cardiac assessment in dogs and cats, at its Westbrook, Maine facility.24d agoIDEXX Laboratories reported second quarter 2026 revenues of $1,217 million, up 10% as reported and 9% organic, with growth across its business segments.31d ago